Clinical Trial Update: Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on risedronate for the prevention of osteoporosis in postmenopausal women; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED